Treatment Options for Chronic Myeloproliferative Disorders
Chronic Myelogenous Leukemia
Polycythemia Vera
Chronic Idiopathic Myelofibrosis
Essential Thrombocythemia
Chronic Neutrophilic Leukemia
Chronic Eosinophilic Leukemia
A link to a list of current clinical trials is included for each treatment section. For some types or stages of cancer, there may not be any trials listed. Check with your doctor for clinical trials that are not listed here but may be right for you.
Chronic Myelogenous Leukemia
See the PDQ summary on Chronic Myelogenous Leukemia Treatment for information.
Polycythemia Vera
The purpose of treatment for polycythemia vera is to reduce the number of extra blood cells. Treatment of polycythemia vera may include the following:
Check for U.S. clinical trials from NCI's PDQ Cancer Clinical Trials Registry that are now accepting patients with polycythemia vera.
Chronic Idiopathic Myelofibrosis
Treatment of chronic idiopathic myelofibrosis in patients without symptoms is usually watchful waiting.
Treatment of chronic idiopathic myelofibrosis in patients with symptoms may include the following:
Check for U.S. clinical trials from NCI's PDQ Cancer Clinical Trials Registry that are now accepting patients with chronic idiopathic myelofibrosis.
Essential Thrombocythemia
Treatment of essential thrombocythemia in patients younger than 60 years who have no symptoms and an acceptable platelet count is usually watchful waiting. Treatment of other patients may include the following:
Check for U.S. clinical trials from NCI's PDQ Cancer Clinical Trials Registry that are now accepting patients with essential thrombocythemia.
Chronic Neutrophilic Leukemia
Treatment of chronic neutrophilic leukemia may include the following:
Check for U.S. clinical trials from NCI's PDQ Cancer Clinical Trials Registry that are now accepting patients with chronic neutrophilic leukemia.
Chronic Eosinophilic Leukemia
Treatment of chronic eosinophilic leukemia may include the following:
Check for U.S. clinical trials from NCI's PDQ Cancer Clinical Trials Registry that are now accepting patients with chronic eosinophilic leukemia.
Back to Top
< Previous Section | Next Section > |